IPO

Plot thickens as Lilly, J&J-backed Protagonist files for $75M IPO

Smith & Nephew spinout Bioventus files for up to $150M IPO

In rare IPO by a VC shop, Draper Esprit raises £102M

Novartis-backed Mereo raises £15M, starts trading on AIM

Israeli biotechs wait in the wings for opening of IPO window

Novimmune’s billionaire backer happy to hang fire on IPO until market improves

Big Pharma-backed Merus edges toward $65M Nasdaq IPO

Medpace seeking $1B public offering: Reuters

Bavarian Nordic gears up for PhII RSV trial after bouncing back from IPO setback

Spotlight: Aeglea raises $50M in IPO after slashing share price